In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents

Biomaterials

Volumn 30, Issue 31, 2009, Pages 6151-6157

  Sakloetsakun, Duangkamon ^a   Hombach, Juliane M R ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Chitosan TGA oxidizing agent systems; In situ gelling; Oxidizing agents; Sol gel transition; Thiomers

Indexed keywords

AGENT SYSTEMS; AMIDE BOND FORMATION; AMMONIUM PERSULFATE; CACO-2 CELLS; CARBOXYLIC ACID GROUPS; CONCENTRATION OF; CONTROLLED DRUG RELEASE; DYNAMIC VISCOSITIES; FREQUENCY SWEEP MEASUREMENT; FUNCTION OF TIME; IN SITU GELLING; INTRAMOLECULAR DISULFIDE BONDS; MODIFIED CHITOSAN; MTT ASSAYS; NEGATIVE CONTROL; OXIDIZING AGENTS; PHARMACEUTICAL APPLICATIONS; PRIMARY AMINO GROUPS; RHEOLOGICAL BEHAVIOUR; RHEOLOGICAL MEASUREMENTS; RHEOLOGICAL STUDIES; SODIUM HYPOCHLORITES; SODIUM PERIODATE; SOL-GEL PHASE TRANSITION; SOL-GEL TRANSITION; THIOGLYCOLIC ACID; THIOL GROUPS; THIOLATED CHITOSAN; THIOMERS;

AMIDES; AMMONIUM COMPOUNDS; CARBOXYLIC ACIDS; CHITIN; COAGULATION; DRUG PRODUCTS; GELATION; GELS; HYDROGEN; HYDROGEN PEROXIDE; ORGANIC ACIDS; OXIDATION; PHASE TRANSITIONS; RHEOLOGY; SODIUM; SOL-GEL PROCESS; SOL-GELS; SOLS; THERMOGRAVIMETRIC ANALYSIS; TISSUE ENGINEERING;

CHITOSAN;

AMIDE; CARBOXYLIC ACID; CHITOSAN; DISULFIDE; DRUG CARRIER; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; LACTATE DEHYDROGENASE; OXIDIZING AGENT; PERIODATE SODIUM; SULFUR DERIVATIVE; THIOGLYCOLIC ACID;

ARTICLE; CELL STRAIN CACO 2; CELL VIABILITY; CHEMICAL BOND; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; FLOW KINETICS; GEL; GELATION; HUMAN; HUMAN CELL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SYNTHESIS; TISSUE ENGINEERING; VISCOSITY;

CACO-2 CELLS; CELL SURVIVAL; CHITOSAN; GELS; HUMANS; L-LACTATE DEHYDROGENASE; POLYMERS; THIOGLYCOLATES; VISCOSITY;

EID: 69649086895     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.07.060     Document Type: Article

References (25)

1. Carlfors J., Edsman K., Petersson R., and Jörnving K. Rheological evaluation of gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 6 2 (1998) 113-119
2. Cheung H.-Y., Lau K.-T., Lu T.-P., Hui, and David. A critical review on polymer-based bio-engineered materials for scaffold development. Compos Part B Eng 38 3 (2007) 291-300
3. Matsusaki M., Yoshida H., and Akashi M. The construction of 3D-engineered tissues composed of cells and extracellular matrices by hydrogel template approach. Biomaterials 28 17 (2007) 2729-2737
4. Balakrishnan B., Mohanty M., Fernandez A.C., Mohanan P.V., and Jayakrishnan A. Evaluation of the effect of incorporation of dibutyryl cyclic adenosine monophosphate in an in situ-forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials 27 8 (2006) 1355-1361
5. Edsman K., Carlfors J., and Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci 6 2 (1998) 105-112
6. Felt O., Buri P., and Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 24 11 (1998) 979-993
7. Kast C., and Bernkop-Schnürch A. Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22 17 (2001) 2345-2352
8. Bernkop-Schnürch A., Hornof M., and Zoidl T. Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm 260 2 (2003) 229-237
9. Hornof M.D., Kast C.E., and Bernkop-Schnürch A. In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Eur J Pharm Biopharm 55 2 (2003) 185-190
10. Krauland A.H., Hoffer M.H., and Bernkop-Schnürch A. Viscoelastic properties of a new in situ gelling thiolated chitosan conjugate. Drug Dev Ind Pharm 31 9 (2005) 885-893
11. Greindl M. Oral drug delivery: design and in vitro/in vivo evaluation of novel permeation enhancers and efflux pump inhibitors (2008), Universtiy of Innsbruck, Innsbruck
12. Bernkop-Schnürch A., Schwarz V., and Steininger S. Polymers with thiol groups: a new generation of mucoadhesive polymers?. Pharm Res 16 6 (1999) 876-881
13. Werle M., and Hoffer M. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 111 1-2 (2006) 41-46
14. Ciapetti G., Cenni E., Pratelli L., and Pizzoferrato A. In vitro evaluation of cell/biomaterial interaction by MTT assay. Biomaterials 14 5 (1993) 359-364
15. Bernkop-Schnürch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev 57 11 (2005) 1569-1582
16. Boontheekul T., Kong H.J., and Mooney D.J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26 15 (2005) 2455-2465
17. Mortazavi S., and Smart J. Factors influencing gel-strengthening at the mucoadhesive-mucus interface. J Pharm Pharmacol 46 2 (1994) 86-90
18. Temenoff J., Shin H., Conway D., Engel P., and Mikos A. In vitro cytotoxicity of redox radical initiators for cross-linking of oligo(poly(ethylene glycol) fumarate) macromers. Biomacromolecules 4 6 (2003) 1605-1613
19. Halliwell B., Clement M., and Long L. Hydrogen peroxide in the human body. FEBS Lett 486 1 (2000) 10-13
20. Millotti G, Hoyer H, Samberger C, Fröhlich E, Bernkop-Schnürch A. Chitosan-6-mercaptonicotinic acid: synthesis, characterization and biocompatibility. Biomacromolecules, in press.
21. Madsen F., Eberth K., and Smart J. A rheological examination of the mucoadhesive/mucus interaction: the effect of mucoadhesive type and concentration. J Control Release 50 1-3 (1998) 167-178
22. Shu X., Liu Y., Palumbo F., and Prestwich G. Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials 24 21 (2003) 3825-3834
23. Hisano N., Morikawa N., Iwata H., and Ikada Y. Entrapment of islets into reversible disulfide hydrogels. J Biomed Mater Res 40 1 (1998) 115-123
24. Balakrishnan B., and Jayakrishnan A. Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds. Biomaterials 26 18 (2005) 3941-3951
25. Blan N., and Birla R. Design and fabrication of heart muscle using scaffold-based tissue engineering. J Biomed Mater Res A 86 1 (2008) 195-208